Fri, January 20, 2023
Thu, January 19, 2023
Wed, January 18, 2023
Tue, January 17, 2023
Mon, January 16, 2023
Sat, January 14, 2023
Fri, January 13, 2023

Liisa Bayko Maintained (ALT) at Buy with Increased Target to $25 on, Jan 18th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-25-on-jan-18th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Liisa Bayko of Evercore ISI Group, Maintained "Altimmune, Inc." (ALT) at Buy with Increased Target from $14 to $25 on, Jan 18th, 2023.

Liisa has made no other calls on ALT in the last 4 months.



There are 2 other peers that have a rating on ALT. Out of the 2 peers that are also analyzing ALT, 0 agree with Liisa's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Liisa


  • Corinne Jenkins of "Goldman Sachs" Initiated at Strong Buy and Held Target at $20 on, Thursday, December 1st, 2022
  • Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $26 on, Friday, November 11th, 2022

Publication Contributing Sources